These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 242206)

  • 41. Graft-versus-host disease.
    Gatti RA; Kersey JH; Yunis EJ; Good RA
    Prog Clin Pathol; 1973; 5():1-18. PubMed ID: 4150104
    [No Abstract]   [Full Text] [Related]  

  • 42. "Spare parts" revisited.
    Rapaport FT
    Transplant Proc; 1975 Sep; 7(3):343-50. PubMed ID: 1099740
    [No Abstract]   [Full Text] [Related]  

  • 43. Prevention of graft-versus-host disease by Fab fragments derived from ALG.
    Richie ER; Gallagher MT; Trentin JJ
    Transplant Proc; 1973 Mar; 5(1):873-6. PubMed ID: 4144467
    [No Abstract]   [Full Text] [Related]  

  • 44. Mechanisms of immunosuppression by antilymphocyte antibody.
    Taub RN
    Pathobiol Annu; 1972; 2():129-51. PubMed ID: 4149315
    [No Abstract]   [Full Text] [Related]  

  • 45. Cellular factors. Immunologic tolerance: irradiation and bone marrow transplantation in induction of canine allogeneic unresponsiveness.
    Rapaport FT; Bachvaroff RJ; Watanabe K; Hirasawa H; Cannon FD; Mollen N; Blumenstock DA; Ayvazian JH; Ferrebee JW
    Transplant Proc; 1977 Mar; 9(1):891-4. PubMed ID: 17203
    [No Abstract]   [Full Text] [Related]  

  • 46. Synergy between injection of F1 spleen cells and thymectomy on maintenance of skin allograft tolerance in adult recipient mice treated with supralethal irradiation followed by syngeneic bone marrow cell transplantation.
    Tomita Y; Mayumi H; Nomoto K
    Transplant Proc; 1990 Feb; 22(1):251-6. PubMed ID: 2137950
    [No Abstract]   [Full Text] [Related]  

  • 47. Inhibition of the graft-versus-host reaction. I. Reduction of the graft-versus-host potential of mouse spleen cells (with a sparing of stem cells) by treatment with antilymphocyte globulin-derived Fab fragments.
    Gallagher MT; Richie ER; Heim LR; Judd KP; Trentin JJ
    Transplantation; 1972 Nov; 14(5):597-602. PubMed ID: 4404282
    [No Abstract]   [Full Text] [Related]  

  • 48. The future of constructive surgery.
    Russell PS
    Transplant Proc; 1974 Dec; 6(4 Suppl 1):147-52. PubMed ID: 4612900
    [No Abstract]   [Full Text] [Related]  

  • 49. The effects of antilymphocyte sera on bone marrow allograft rejection.
    Riches AC; Thomas DB
    Exp Hematol; 1975 Jun; 3(3):169-80. PubMed ID: 1098919
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Some critical remarks and suggestions about antilymphocyte serum.
    Grabar P
    Transplant Proc; 1972 Sep; 4(3):407-13. PubMed ID: 4628101
    [No Abstract]   [Full Text] [Related]  

  • 51. New approaches to immunosuppression in renal transplantation.
    Stuart FP
    Urol Clin North Am; 1976 Oct; 3(3):575-96. PubMed ID: 790732
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Conditioning recipients of hemopoietic cells with antilymphocytic serum (ALS) and partial-body irradiation.
    Kolb H; Thierfelder S; Baumann P; Balk O
    Rev Eur Etud Clin Biol; 1971 Oct; 16(8):810-4. PubMed ID: 4399647
    [No Abstract]   [Full Text] [Related]  

  • 53. Thymosin, a thymic hormone influencing lymphoid cell immunological competence.
    White A; Goldstein AL
    Ciba Found Study Group; 1970; 36():3-23. PubMed ID: 4399435
    [No Abstract]   [Full Text] [Related]  

  • 54. Specific tolerance to canine renal allografts following treatment with fractionated bone marrow and antilymphocyte serum.
    Hartner WC; De Fazio SR; Markees TG; Maki T; Monaco AP; Gozzo JJ
    Transplant Proc; 1987 Feb; 19(1 Pt 1):476-7. PubMed ID: 3274810
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bone marrow transplantation in inbred strains of mice. I. The failure of development of normal T cell function following allogeneic transplantation.
    Trier L; Rubin B
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1974 Oct; 82B(5):724-32. PubMed ID: 4139875
    [No Abstract]   [Full Text] [Related]  

  • 56. Total lymphoid irradiation.
    Sutherland DE; Ferguson RM; Simmons RL; Kim TH; Slavin S; Najarian JS
    Urol Clin North Am; 1983 May; 10(2):277-88. PubMed ID: 6344387
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The cellular basis of transplantation tolerance.
    Elkins WL
    Transplant Proc; 1973 Mar; 5(1):685-9. PubMed ID: 4144461
    [No Abstract]   [Full Text] [Related]  

  • 58. Antilymphocytic antibodies and marrow transplantation. IV. Comparison of the effects of antibody fragments directed against immunoglobulin or lymphocyte antigens on acute secondary disease.
    Rodt H; Therfelder S; Eulitz M
    Exp Hematol; 1974; 2(4):195-203. PubMed ID: 4156327
    [No Abstract]   [Full Text] [Related]  

  • 59. [Antilymphocyte serum as an immunosuppressant].
    Wiig JN
    Tidsskr Nor Laegeforen; 1973 Mar; 93(9):574-8. PubMed ID: 4148532
    [No Abstract]   [Full Text] [Related]  

  • 60. Induction of unresponsiveness to skin and heart allografts in mice by a synergistic treatment with procarbazine, antilymphocyte serum, and donor-type cells.
    Floersheim GL
    Transplantation; 1973 Feb; 15(2):195-205. PubMed ID: 4146168
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.